These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11207885)

  • 21. [Use of driptan (oxybutinin) in patients with urgent forms of urination disorders].
    Loran OB; Pushkar' DIu; Tevlin KP
    Urol Nefrol (Mosk); 1998; (6):24-6. PubMed ID: 10051823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects.
    Bemelmans BL; Kiemeney LA; Debruyne FM
    Eur Urol; 2000 Jun; 37(6):709-13. PubMed ID: 10828672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

  • 24. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.
    Gish P; Mosholder AD; Truffa M; Johann-Liang R
    J Pediatr; 2009 Sep; 155(3):432-4. PubMed ID: 19732583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic use of oxybutynin and spinal anesthesia: a case of postoperative urinary retention and hematuria.
    Hobaika AB
    Middle East J Anaesthesiol; 2011 Oct; 21(3):431-2. PubMed ID: 22428504
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients.
    Wang PS; Levin R; Zhao SZ; Avorn J
    J Am Geriatr Soc; 2002 Jan; 50(1):117-24. PubMed ID: 12028256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can oxybutynin cause peripheral neuropathy?
    Patel HR; Albehussi S; Arya M; Miller RA
    J Urol; 2002 Aug; 168(2):646. PubMed ID: 12131334
    [No Abstract]   [Full Text] [Related]  

  • 28. A case of oxybutynin dependency.
    Guloksuz S; Eren K; Gurol DT
    Gen Hosp Psychiatry; 2010; 32(4):e5-6. PubMed ID: 20633735
    [No Abstract]   [Full Text] [Related]  

  • 29. A benefit-risk assessment of extended-release oxybutynin.
    Michel MC
    Drug Saf; 2002; 25(12):867-76. PubMed ID: 12241127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal oxybutynin (oxytrol) for urinary incontinence.
    Dull P
    Am Fam Physician; 2004 Dec; 70(12):2351-2. PubMed ID: 15617300
    [No Abstract]   [Full Text] [Related]  

  • 32. Epistaxis as a side effect of oxybutynin in children: report of two cases.
    Batista JE; Caffaratti J; Garat JM
    Neurourol Urodyn; 1994; 13(1):85-6. PubMed ID: 8156079
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe Xerostomia Secondary to Anticholinergic Drug Therapy: Case Report.
    Brown RS; Rhodes BH; Siewe MS; Matthews TJ
    Dent Today; 2017 Feb; 36(2):136-8. PubMed ID: 29235767
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxybutynin and cognitive dysfunction.
    Donnellan CA; Fook L; McDonald P; Playfer JR
    BMJ; 1997 Nov; 315(7119):1363-4. PubMed ID: 9402781
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of medication-associated initiation of oxybutynin in elderly men and women.
    Kalisch Ellett LM; Pratt NL; Barratt JD; Rowett D; Roughead EE
    J Am Geriatr Soc; 2014 Apr; 62(4):690-5. PubMed ID: 24635879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

  • 37. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
    Bary PR; Moisey CU; Stephenson TP; Brendler CB
    Prog Clin Biol Res; 1981; 78():313-9. PubMed ID: 7038709
    [No Abstract]   [Full Text] [Related]  

  • 38. [Parkinsonism induced by propiverine hydrochloride--report of 3 cases].
    Sugiyama Y
    Rinsho Shinkeigaku; 1997 Oct; 37(10):873-5. PubMed ID: 9490895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxybutynin extended-release: a review of its use in the management of overactive bladder.
    Siddiqui MA; Perry CM; Scott LJ
    Drugs; 2004; 64(8):885-912. PubMed ID: 15059046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.